drugset / Trial / NCT00453817
Islet of Langerhans Graft Monitoring by Magnetic Resonance Imaging
Non-randomizedSingle-groupOpen-labelDiagnostic
Summary
The primary objective of this pilot study is to assess the feasibility and safety of ex vivo islet labelling prior to intraportal transplantation in patients with type 1 diabetes with the purpose of islet graft imaging. The secondary objective is to determine the usefulness of this method for long-term islet graft monitoring.
Timeline
- Start
- 2005-06
- Primary completion
- 2010-06
- Completion
- 2010-06
Outcome
Outcome not reported
Stopped: “Feasibility issues”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ferucarbotran | Diagnostic / imaging agent | — | — |